Company news

Cynata Therapeutics Limited news in 2019

Cynata Therapeutics Limited's news releases, calls and decks from 2019, newest first.

View company

Cymerus MSCs Effective in Preclinical Model of Sepsis

December 4, 2019

CYP Files Application to Commence Phase 2 CLI Clinical Trial

November 24, 2019

Cynata Awarded Grant for Coronary Artery Disease Study

October 27, 2019

Notice of Allowance from CIPO for Patent Application

October 24, 2019

September 2019 Quarterly Report

October 23, 2019

Cynata & Sumitomo Withdraw from Acquisition Discussions

October 16, 2019

CYP Advances Towards Osteoarthritis Phase 2 Clinical Trial

October 2, 2019

Cynata Receives US$3 million Fujifilm License Fee

September 25, 2019

Fujifilm Exercises License Option in GvHD

September 17, 2019

Update on Discussions with Sumitomo and Fujifilm

August 14, 2019

Response to ASX Aware Query

July 24, 2019

Response to ASX Price and Volume Query

July 19, 2019

Cynata confirms receipt of indicative non-binding proposal

July 18, 2019

June 2019 Quarterly Report

July 4, 2019

Cynata Strengthens Board & Executive Management Team

May 19, 2019

March 2019 Quarterly Report

April 26, 2019

Cynata Extends FUJIFILM Licence Option in GvHD

March 20, 2019

Cynata Receives Favourable Advice on Planned CLI Trial

March 11, 2019

December 2018 Quarterly Report

January 29, 2019

CYP Receives Notice of Acceptance from Aust Patent Office

January 6, 2019

Decks in 2019